LY-01007

N/A

Report date: 2025/03/26 20:01:25
NME

Base Information

Drug NameLY-01007
Drug Alias Name注射用醋酸曲普瑞林缓释微球LY01007
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsPuberty, PrecociousInfertility, FemaleEndometriosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Luye Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Luye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsPuberty, PrecociousInfertility, FemaleEndometriosis +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG